Target intelligence / Profile preview

Tight junction proteins in intestinal cells

Molecular classification
Integral membrane proteins (Occludin, Claudins, JAMs, Tricellulin), Peripheral membrane adaptor proteins (Zonula occludens proteins: ZO-1, ZO-2, ZO-3), Scaffold proteins
01

Overview

Tight junction proteins in intestinal cells are multi-component complexes at the apical-lateral border which seal the paracellular space between neighboring epithelial cells. The major integral membrane proteins involved are Occludin, the Claudin family, Junctional adhesion molecules (JAMs), and Tricellulin, with Zonula occludens (ZO) proteins acting as cytoskeletal adaptors. These proteins are essential for maintaining the intestinal barrier, regulating the paracellular passage of ions, water, solutes, and excluding pathogens and antigens. Disruption leads to barrier dysfunction, observed in inflammatory, infectious, and metabolic diseases. Tight junction proteins are dynamically regulated by intracellular signaling pathways and undergo post-translational modifications (especially phosphorylation), which alter their interactions with the cytoskeleton, their localization, and barrier function. Pharmaceutical strategies aim to stabilize or restore their function in disease states.

Other names
TJ proteinsIntestinal tight junction proteinsCell junction proteinsParacellular barrier proteins
02

Mechanism of action

Stabilization of TJ proteins to reduce pathological permeability. Inhibition of kinase-mediated phosphorylation disrupting TJ assembly (e.g., MLCK inhibitors block MLC phosphorylation, preserve barrier function). Modulation of inflammatory cytokine signaling (inhibition of TNF-α, IFN-γ reduces TJ protein internalization and redistribution). Enhancement of protein expression (e.g., promotion of Occludin/Claudins increases TJ integrity).

03

Biological functions

Regulation of intestinal barrier function (paracellular permeability)Maintenance of mucosal immune defenseSignal transduction (interaction with signaling pathways such as PKC, MLCK, MAPK, PI3K/Akt)Cell adhesionCellular polarity
04

Disease associations

Inflammatory diseases (Inflammatory bowel disease, Crohn’s disease, ulcerative colitis)Cancer (barrier dysfunction may promote tumorigenesis)Infection (altered barrier allows pathogen invasion)Metabolic syndromes (altered permeability)Systemic diseases from barrier failure
05

Safety considerations

Off-target effects: Broadly targeting TJ proteins can disrupt essential physiological barrier functions, leading to increased infection risk, immune activation, diarrhea, and malabsorption.Therapeutic challenges: Tissue- and isoform-specific expression of various TJ proteins complicates drug design for selective targeting.Rapid turnover/dynamics of TJ assembly pose dosing/timing difficulties.
06

Interacting drugs

Larazotide acetate (targets TJ regulation, mainly Claudins and Occludin; orphan drug status for celiac disease)

3 more in the full profile.

07

Biomarkers

Occludin and Claudin expression levels (for barrier integrity assessment)Paracellular permeability markers (e.g., lactulose-mannitol test)Zonula occludens-1 (ZO-1) protein levels (indicator of TJ status)

Beyond the preview

Go deeper on Tight junction proteins in intestinal cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tight junction proteins in intestinal cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call